, to the extent that e-commerce social platform Xiaohongshu installed a pop-up alert telling those searcing for the drug to"go to formal medical facilities for treatment," per CNN.
The platform has also deleted thousands of posts by people sharing their experiences with the drug, CNN reported. China's medical industry is now rushing to catch up, with one company, Huadong Medicine Co, challenging semaglutide manufacturer Novo Nordisk for its patent, Bloomberg reported. Subscribe to push notifications
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: